SARS CoV 2 News and Research

RSS

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

Researchers assessed the humoral immune responses generated by the third Pfizer-BioNTech BNT162b2 mRNA vaccination against SARS-CoV-2 among hemodialysis patients.

30 May 2022

Researchers evaluate atovaquone as a COVID-19 treatment

Researchers evaluated a drug, atovaquone, for COVID-19 treatment.

30 May 2022

Researchers report the case of a non-vaccinated patient coinfected with SARS-CoV-2 Omicron BA.1 and BA.2

A recent study published in The Lancet Microbe described the case of a non-vaccinated female coinfected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1 and BA.2 subvariants.

30 May 2022

SARS-CoV-2 virus entered the United States one month before the official date, study reveals

Researchers from the Department of Applied Mathematics and the Ramón Margalef Multidisciplinary Institute for Environmental Research (IMEM) at the University of Alicante (UA) continue to make progress in the study of the spread of COVID-19.

30 May 2022

Excess deaths in Canada during COVID-19 pandemic vary widely by province, analysis shows

An analysis of excess deaths in Canada during the COVID-19 pandemic shows wide variation by province and underscores the need for better and consistent data for current and future health crisis management.

30 May 2022

Investigating post-COVID complaints after Delta versus Omicron variant infections

A new study discusses whether infection with the SARS-CoV-2 Omicron variant increases the risk of post-COVID complaints Delta infection.

30 May 2022

Investigating incidence and clinical features of post-acute sequelae of COVID-19 in children and adolescents

Researchers identify symptoms and systematic conditions associated with PASC in children

30 May 2022

Increase in depression and anxiety rates in the U.K. identified during COVID-19 lockdowns

Researchers discuss changes in depressive and anxiety symptoms during the COVID-19 pandemic.

30 May 2022

Study finds long-term exposure to common air pollutants is associated with COVID-19 severity

Researchers evaluate the relationship between long-term exposure to three common air pollutants and key indicators of COVID-19 severity.

30 May 2022

Neurological symptoms may persist for over one year in long-COVID patients

Patients who have recovered from COVID-19 are likely to experience persistent neurologic symptoms for a median of 14.8 months following their initial infection.

30 May 2022

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

A new study utilizes multisystem imaging, along with biomarker analysis, to better understand the pathogenesis of COVID-19.

30 May 2022

Study finds TGF-β2 associated with asymptomatic mild SARS-CoV-2 infection during pregnancy

A new study investigated the clinical and obstetric outcomes after SARS-CoV-2 infection in two groups of pregnant women, along with their association with the immunological parameters.

28 May 2022

Pediatric patients with prior COVID-19 or MIS-C are not protected against Omicron

Research drawing on the national Overcoming COVID-19 study, led by Boston Children's Hospital, and the hospital's own Taking On COVID-19 Together Group provides evidence that children who previously had COVID-19 (or the inflammatory condition MIS-C) are not protected against the newer Omicron variant.

27 May 2022

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

Researchers compared the polymer-nanoparticle hydrogel system and standard routes of delivery of broadly neutralizing antibodies against SARS-CoV-2 in a mouse model.

27 May 2022

Exploring antigenic traits of SARS-CoV-2 Omicron BA.5 and BA.4 subvariants

Scientists analyzed the antigenic characteristics of the severe acute respiratory syndrome coronavirus 2 Omicron BA.5 and BA.4 sublineages.

27 May 2022

SARS-CoV-2 genome analysis could boost disease surveillance

Continued monitoring of the evolution of the virus that causes COVID-19 as the pandemic progresses could strengthen disease surveillance systems and aid preparedness for new variants, a study suggests.

27 May 2022

COVID-19 found to be among the top 10 causes of mortality in children and youth in the United States

Researchers retrieved CDC data for causes of death by age group for 2019 and compared it to the cumulative and annualized COVID-19 mortality between March 2020 and April 2022.

27 May 2022

Short-term immunity imparted by COVID-19 BNT162b2 vaccination in adolescents and children

Researchers demonstrated the short-term protection conferred by the SARS-CoV-2 BNT162b2 vaccination in adolescents and children.

27 May 2022

Exploring the effect of genetic variability on COVID-19 infection and severity

Researchers demonstrated how narrow-sense heritability (h2) leads to variability in the susceptibility to COVID-19 infection and severity among different individuals.

27 May 2022

Nexus Medical Labs receives FDA Emergency Use Authorization for SARS-CoV-2 test using the RHINOstic™ Automated Nasal Swab from Rhinostics

Rhinostics Inc. and Nexus Medical Labs recently received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a molecular SARS-CoV-2 test enabling unsupervised self-collection.

From Rhinostics 27 May 2022

SARS CoV 2 News and Research

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

Researchers evaluate atovaquone as a COVID-19 treatment

Researchers report the case of a non-vaccinated patient coinfected with SARS-CoV-2 Omicron BA.1 and BA.2

SARS-CoV-2 virus entered the United States one month before the official date, study reveals

Excess deaths in Canada during COVID-19 pandemic vary widely by province, analysis shows

Investigating post-COVID complaints after Delta versus Omicron variant infections

Investigating incidence and clinical features of post-acute sequelae of COVID-19 in children and adolescents

Increase in depression and anxiety rates in the U.K. identified during COVID-19 lockdowns

Study finds long-term exposure to common air pollutants is associated with COVID-19 severity

Neurological symptoms may persist for over one year in long-COVID patients

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

Study finds TGF-β2 associated with asymptomatic mild SARS-CoV-2 infection during pregnancy

Pediatric patients with prior COVID-19 or MIS-C are not protected against Omicron

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

Exploring antigenic traits of SARS-CoV-2 Omicron BA.5 and BA.4 subvariants

SARS-CoV-2 genome analysis could boost disease surveillance

COVID-19 found to be among the top 10 causes of mortality in children and youth in the United States

Short-term immunity imparted by COVID-19 BNT162b2 vaccination in adolescents and children

Exploring the effect of genetic variability on COVID-19 infection and severity

Nexus Medical Labs receives FDA Emergency Use Authorization for SARS-CoV-2 test using the RHINOstic™ Automated Nasal Swab from Rhinostics

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News